Vaginal stimulation (VS) in virgin female rats on the first day of estrous induces a significant increase in serum prolactin levels 15 min, 6,9,10 and 12 h after stimulation. Normal level values were observed 2 h after VS but a significant decrease appeared 8 h after VS. In nonstimulated rats a significant variation was observed, with a peak at 10.00 and 18.00 h and minimal values at 12.00 and 16.00. Adenohypophysial prolactin concentration showed a significant decrease both 15 min and 6 h after VS. A significant increase occurred 4 h after VS. At 8, 9, 10 and 12 h after cervical stimulation, the levels of prolactin were similar to levels in the control rats. The curve obtained in nonstimulated rats showed a significant decrease between 10.00 and 12.00 h; the rest of the curve showed no significant variation. The levels of prolactin in the hypophysis and serum during the first 12 h after VS clearly show a phasic release of the hormone and a correlation between synthesis and release, suggesting the existence of some kind of neural hormonal factor of regulation.

Keywords:
Vaginal stimulation (VS), Prolactin synthesis and release, Pseudopregnancy
This content is only available via PDF.
© 1974 S. Karger AG, Basel
1973
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.